Provided by Tiger Trade Technology Pte. Ltd.

Jasper Therapeutics

0.7114
+0.01171.67%
Post-market: 0.6972-0.0142-2.00%19:44 EDT
Volume:388.05K
Turnover:271.81K
Market Cap:23.67M
PE:-0.76
High:0.7400
Open:0.7149
Low:0.6545
Close:0.6997
52wk High:2.87
52wk Low:0.3151
Shares:33.27M
Float Shares:30.00M
Volume Ratio:1.39
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-3.9545
ROE:-255.05%
ROA:-113.41%
PB:16.75
PE(LYR):-0.18

Loading ...

Feb 27, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 17, 2023

Major Issues Report

8-K - Current report
Feb 16, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 30, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2023

Major Issues Report

8-K - Current report
Jan 25, 2023

Major Issues Report

8-K - Current report
Jan 24, 2023

Major Issues Report

8-K - Current report
Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Major Issues Report

8-K - Current report
Jan 10, 2023

Major Issues Report

8-K - Current report
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 04, 2022

Major Issues Report

8-K - Current report